Clinical trial
Randomized Study of Beta Interferon and Thalidomide in Patients With…
NCT00004450 · FDA Office of Orphan Products Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00004450 |
|---|---|
| Title | Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy |
| Lead sponsor | FDA Office of Orphan Products Development, U.S. Fed |
| Collaborators | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. |
| Status | Completed |
| Study type | Interventional |
| Conditions | Adrenoleukodystrophy |
| Intervention type | Drug |
| Interventions | glyceryl trierucate, glyceryl trioleate, interferon beta, thalidomide |
| Enrollment | 60 |
| Start date | Aug 1, 1998 |
| Completion | Nov 1, 2000 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 25, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: